Our Medicines
We are a global biopharmaceutical company focused on helping to address the unmet medical needs of patients with serious diseases. We are investing billions in Research and Development (R&D), which includes the discovery and development of new medicines.
OPDYTA® (Nivolumab) YERVOI® (Ipilimumab) ROJUZDA® (Luspatercept) |
|
Product Information for Healthcare Professionals
ONC-IN-2100116 valid till 7 Oct 2022